Health ❯ Neurology

Alzheimer's Disease

Cognitive Decline Risk Factors Symptoms Research Biomarkers Research Studies Cognitive Function Clinical Trials Diagnosis Genetic Risk Factors

Neumora Halts Navacaprant After Phase 3 KOASTAL Failures

A roughly 35% workforce reduction will fund a pivot to three earlier-stage programs, preserving cash into the third quarter of 2027.

Eli Lilly Licenses AlzeCure’s Preclinical Alzheimer’s Candidate

New Ubiquitin Tag Drives Fear Memory in Female Rat Hippocampus

Physics-Informed AI Maps Brain-Wide Glymphatic Flow

Irma Maury’s One-Word Facebook Post ‘Alzheimer’ Alarms Fans

Major Review Links Exercise, Sleep, and Sitting to Dementia Risk

GLP-1 Drugs Linked to Lower Addiction Risk and Harm in Large VA Study

Studies Link GLP-1 Drugs to Lower Addiction and Overdose Risks

Exercise-Linked Liver Enzyme Restores Brain Barrier and Memory in Aging Mice

Massive U.S. Study Links Fine-Particle Pollution to Higher Alzheimer’s Risk

‘Memory of a Killer’ Sets UK Prime Video Launch as FOX Run Reaches Week 3

FDA Grants Priority Review to Axsome’s AXS-05 for Alzheimer’s Agitation, Sets April 30 PDUFA Date

St Andrews Study Finds Social Isolation Directly Speeds Cognitive Decline

WHO Backs GLP-1 Weight-Loss Drugs as New Data Highlight Limits and Unknowns

Novo Nordisk’s Oral Semaglutide Fails to Slow Alzheimer’s in Dual Phase 3 Trials

Michael Jordan Gives $10 Million to Novant Health for Wilmington Neuroscience Institute Honoring His Mother

Study Links Lower Income to Heavier Load of Modifiable Dementia Risks, With Vision Loss and Isolation Standing Out

Men’s Brains Shrink Faster With Age Than Women’s, Large MRI Study Finds

Alector Ends Latozinemab After Phase 3 Failure, Slashes Workforce

Nanoparticles Restore Brain Barrier, Reverse Alzheimer’s Signs in Mice